Gufic BioSciences Ltd.

NSE: GUFICBIO | BSE: 509079 | ISIN: INE742B01025 | Industry: Pharmaceuticals
| Expensive Performer
408.4500 -8.65 (-2.07%)
NSE Oct 15, 2026 15:31 PM
Volume: 33,339
 

408.45
-2.07%
KamayaKya Wealth
Going forward, we estimate a 20% CAGR till FY24 (based on non COVID-19 products), driven by doubling of capacities in the lyophilisation segment, increase in market share of niche products and new product launches coupled with geographical expansion.
Gufic BioSciences has gained 32.98% in the last 6 Months
More from Gufic BioSciences Ltd.
Recommended